Laformin-G Forte 2mg/1000mg Tablet is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, resulting in reduced blood glucose levels. This dual mechanism addresses both insulin deficiency and insulin resistance, making Laformin-G Forte effective for patients inadequately controlled on monotherapy or lifestyle interventions alone. The tablet is typically administered once daily with meals to minimize gastrointestinal side effects associated with Metformin. It is essential to monitor renal function prior to initiation and periodically thereafter, as Metformin is contraindicated in patients with significant renal impairment due to the risk of lactic acidosis. Common adverse effects include hypoglycemia, particularly due to Glimepiride, gastrointestinal disturbances such as nausea and diarrhea, and potential weight gain. Patient education on adherence, diet, exercise, and recognition of hypoglycemia symptoms is crucial. Laformin-G Forte should be used under medical supervision with regular monitoring of blood glucose and HbA1c to optimize therapeutic outcomes.